Sandra Drug Co., Ltd. <9989> saw a significant rebound. They announced their November monthly trends the previous day, which seems to have led to buying interest. The group total same-store sales increased by 2.6% year-on-year, marking two consecutive months of positive growth. The drugstore business saw a 2.4% increase, representing a return to positive growth after two months. It appears seasonal products are driving this trend. In the future, as last year's hurdles gradually lower, further growth is expected.
サンドラッグ---大幅反発、11月既存店の堅調推移を評価
Sandra Drug - Significant rebound, evaluating the steady performance of existing stores in November.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.